- . , - M.Sc.,

?

: , .

. (Centers for Disease Controls and Prevention)

Centers for Disease Control

: .

70% (~1,7 ).

(World Health Organization)

7 /10 .

86% .

(World Health Organization)

. , .

(World Health Organization)

- .

(Centers for Disease Controls and Prevention)

.

(Blair, Horton et al 1996)

:

.

(World Health Organization Centers for Disease Controls and Prevention)

() .

( ) .

(World Health Organization Centers for Disease Controls and Prevention)

.

.

( !!)

(World Health Organization Centers for Disease Controls and Prevention)

: . .: . LDL & tChol3, 6, , , .

(World Health Organization Centers for Disease Controls and Prevention)

. K , . ( ).

(World Health Organization Centers for Disease Controls and Prevention)

5 . , , .

(World Health Organization Centers for Disease Controls and Prevention)

. 25-30%. . 2

(World Health Organization Centers for Disease Controls and Prevention)

. ( 1 / , 2 // ).

TG, HDL .

.

(World Health Organization Centers for Disease Controls and Prevention)

. . , , , . : .

(Willett, Sacks et al 1995)

: (9%) (9%) (6%) Parkinson Alzheimer (13%)

(Sofi, Cesari et al 2008)

80% , .

.

.

(Centers for Disease Controls and Prevention)

- .: . :

... .

(International Pharmaceutical Federation Pharmaceutical Society of Australia)

. . & . .... .

(International Pharmaceutical Federation Pharmaceutical Society of Australia)

:

.

.

(International Pharmaceutical Federation Pharmaceutical Society of Australia)

, .

(Smith, Bates et al 2010)

, . , .

(Smith, Bates et al 2010 Praddep, Molina et al 2010)

.

( ), .

(International Pharmaceutical Federation Pharmaceutical Society of Australia)

-: . .. (, , )

(International Pharmaceutical Federation Pharmaceutical Society of Australia)

& .

, , .

(World Health Organization Centers for Disease Controls and Prevention)

...

( ), .

... - . , - M.Sc.,